ACAD
ACAD
NASDAQ · Biotechnology

Acadia Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$21.24
-0.23 (-1.07%)
As of Nov 5, 9:59 PM ET ·
ACAD News2 articles
Dow Hits Record High as Chip Slump Splits Wall Street
The Dow climbed to a record high Tuesday as strong bank earnings offset a global chip selloff, while the Nasdaq slipped and the S&P 500 stayed flat.
Markets
Acadia Pharma Governance Overhaul Approved, No Cash for Shareholders
Acadia Pharmaceuticals' derivative settlement brings four years of governance reforms, not cash payouts. A federal court will consider final approval in January 2027.
Regulation